Being vigilant about any unusual symptoms and promptly reporting them to a healthcare provider is essential for managing risks
Before you treat two prices as comparable, check what the number includes and what could appear later
In ACHIEVE-1 , the first of seven Phase 3 studies in people with type 2 diabetes, orforglipron reduced A1C by an average of 1.3% to 1.6% across doses compared to placebo at 40 weeks, starting from a baseline of 8.0%
Device manufacturers must reevaluate product pipelines in light of declining procedural volume
After a single injection of CJC-1295 in healthy adults, GH rises 2- to 10-fold and IGF-1 increases 1.5- to 3-fold over baseline for several days
For patients with diabetes, careful glucose monitoring is essential, particularly during dose titration, to identify and prevent hypoglycemia